Patents by Inventor Ryan Jefferson Watts

Ryan Jefferson Watts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for improving safety of blood-brain barrier transport
    Patent number: 11167038
    Abstract: The present invention relates to compositions and methods for improving the safety of blood-brain barrier receptor-mediated blood-brain barrier transport.
    Type: Grant
    Filed: July 12, 2018
    Date of Patent: November 9, 2021
    Assignee: Genentech, Inc.
    Inventors: Ryan Jefferson Watts, Joy Yu Zuchero, Jessica Couch, Mark Dennis
  • Low Affinity Blood Brain Barrier Receptor Antibodies and Uses Thereof
    Publication number: 20210292440
    Abstract: The present invention relates to antibodies that bind blood brain barrier receptors (BBB-R) and methods of using the same.
    Type: Application
    Filed: January 28, 2021
    Publication date: September 23, 2021
    Applicant: Genentech, Inc.
    Inventors: Mark Dennis, Ryan Jefferson Watts, Yunhua Yu Zuchero, Yin Zhang
  • Low affinity blood brain barrier receptor antibodies and uses thereof
    Patent number: 10941215
    Abstract: The present invention relates to antibodies that bind blood brain barrier receptors (BBB-R) and methods of using the same.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: March 9, 2021
    Assignee: Genentech, Inc.
    Inventors: Mark Dennis, Ryan Jefferson Watts, Yunhua Yu Zuchero, Yin Zhang
  • LOW AFFINITY BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES AND USES THEREOF
    Publication number: 20190202936
    Abstract: The present invention relates to antibodies that bind blood brain barrier receptors (BBB-R) and methods of using the same.
    Type: Application
    Filed: September 14, 2018
    Publication date: July 4, 2019
    Applicant: Genentech, Inc.
    Inventors: Mark DENNIS, Ryan Jefferson WATTS, Yunhua Yu ZUCHERO, Yin ZHANG
  • METHODS FOR IMPROVING SAFETY OF BLOOD-BRAIN BARRIER TRANSPORT
    Publication number: 20190030160
    Abstract: The present invention relates to compositions and methods for improving the safety of blood-brain barrier receptor-mediated blood-brain barrier transport.
    Type: Application
    Filed: July 12, 2018
    Publication date: January 31, 2019
    Applicant: Genentech, Inc.
    Inventors: Ryan Jefferson Watts, Joy Yu Zuchero, Jessica Couch, Mark Dennis
  • LOW AFFINITY BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES AND USES THEREOF
    Publication number: 20170260292
    Abstract: The present invention relates to antibodies that bind blood brain barrier receptors (BBB-R) and methods of using the same.
    Type: Application
    Filed: February 17, 2017
    Publication date: September 14, 2017
    Applicant: Genentech, Inc.
    Inventors: Mark DENNIS, Ryan Jefferson WATTS, Yunhua Yu ZUCHERO, Yin ZHANG
  • Low affinity blood brain barrier receptor antibodies and uses therefor
    Patent number: 9611323
    Abstract: The present invention relates to antibodies that bind blood brain barrier receptors (BBB-R) and methods of using the same.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: April 4, 2017
    Assignee: Genentech, Inc.
    Inventors: Mark Dennis, Ryan Jefferson Watts, Yunhua Joy Yu, Yin Zhang
  • METHODS FOR IMPROVING SAFETY OF BLOOD-BRAIN BARRIER TRANSPORT
    Publication number: 20150353639
    Abstract: The present disclosure relates to compositions and methods for improving the safety of blood-brain barrier receptor-mediated blood-brain barrier transport.
    Type: Application
    Filed: May 20, 2013
    Publication date: December 10, 2015
    Inventors: Ryan Jefferson Watts, Joy Yu Zuchero, Jessica Couch, Mark Dennis
  • LOW AFFINITY BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES AND USES THEREFOR
    Publication number: 20150329636
    Abstract: The present invention relates to antibodies that bind blood brain barrier receptors (BBB-R) and methods of using the same.
    Type: Application
    Filed: December 19, 2014
    Publication date: November 19, 2015
    Applicant: GENENTECH, INC.
    Inventors: Mark Dennis, Ryan Jefferson Watts, Yunhua Joy Yu, Yin Zhang
  • Inhibition of tumor metastasis by anti-neuropilin 2 antibodies
    Patent number: 8920805
    Abstract: The invention provides Nrp2 antagonists, such as anti-Nrp2 antibodies, and their use in the prevention and treatment of tumor metastasis.
    Type: Grant
    Filed: June 11, 2013
    Date of Patent: December 30, 2014
    Assignee: Genentech, Inc.
    Inventors: Yan Wu, Wei-Ching Liang, Ryan Jefferson Watts, Anil Durgadas
  • INHIBITION OF TUMOR METASTASIS
    Publication number: 20140234312
    Abstract: The invention provides Nrp2 antagonists, such as anti-Nrp2 antibodies, and their use in the prevention and treatment of tumor metastasis.
    Type: Application
    Filed: June 11, 2013
    Publication date: August 21, 2014
    Applicant: GENENTECH, INC.
    Inventors: Yan Wu, Wei-Ching Liang, Ryan Jefferson Watts, Anil Durgadas
  • Inhibition of tumor metastasis by anti neuropilin 2 antibodies
    Patent number: 8648173
    Abstract: The application provides Nrp2 antagonists, such as anti-Nrp2 antibodies, and their use in the prevention and treatment of tumor metastasis.
    Type: Grant
    Filed: May 17, 2007
    Date of Patent: February 11, 2014
    Assignee: Genentech, Inc.
    Inventors: Yan Wu, Wei-Ching Liang, Ryan Jefferson Watts, Anil Durgadas Bagri
  • LOW AFFINITY BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES AND USES THEREFOR
    Publication number: 20120171120
    Abstract: The present invention relates to antibodies that bind blood brain barrier receptors (BBB-R) and methods of using the same.
    Type: Application
    Filed: November 29, 2011
    Publication date: July 5, 2012
    Applicant: Genentech, Inc.
    Inventors: Mark Dennis, Ryan Jefferson Watts, Yunhua Joy Yu, Yin Zhang
  • INHIBITION OF TUMOR METASTASIS BY ANTI NEUROPILIN 2 ANTIBODIES
    Publication number: 20100172921
    Abstract: The application provides Nrp2 antagonists, such as anti-Nrp2 antibodies, and their use in the prevention and treatment of tumor metastasis.
    Type: Application
    Filed: May 17, 2007
    Publication date: July 8, 2010
    Inventors: Yan Wu, Wei-Ching Liang, Ryan Jefferson Watts, Anil Durgada Bagri